Lhasa Limited

shared knowledge shared progress

ABOUT US |
CONTACT US |
CAREERS |
Login

Related News

Lhasa Limited continues to support the global challenge of nitrosamine impurity assessment
With 164 new nitrite results, bringing the total number to 440 nitrite results for 64 common excipients, Lhasa Limited is pleased to announce the release of the 2021.1 Nitrites in Excipients database.
05 March 2021
Lhasa Limited releases new data to its Nitrites in Excipients project users
15 December 2020
Lhasa Limited releases new data to its Aromatic Amines project users
26 November 2020

Related Blog Articles

The top 5 benefits of data sharing with Vitic [an infographic]
Lhasa Limited has been an advocate of data sharing for many years. In this piece, we explore the top 5 benefits of data sharing with Vitic.
08 April 2021
Working together to address the potential presence of nitrosamine impurities in medications
25 January 2021
Lhasa Limited supports the global challenge of nitrosamine impurity assessment
13 July 2020

Recent News

Lhasa Limited continues to support the global challenge of nitrosamine impurity assessment
With 164 new nitrite results, bringing the total number to 440 nitrite results for 64 common excipients, Lhasa Limited is pleased to announce the release of the 2021.1 Nitrites in Excipients database.
05 March 2021

Recent Blog Articles

The top 5 benefits of data sharing with Vitic [an infographic]
Lhasa Limited has been an advocate of data sharing for many years. In this piece, we explore the top 5 benefits of data sharing with Vitic.
08 April 2021

Recent Publications

Upcoming Events

Recent News

Lhasa Limited continues to support the global challenge of nitrosamine impurity assessment
With 164 new nitrite results, bringing the total number to 440 nitrite results for 64 common excipients, Lhasa Limited is pleased to announce the release of the 2021.1 Nitrites in Excipients database.
05 March 2021
Lhasa Limited releases new data to its Nitrites in Excipients project users
15 December 2020
Lhasa Limited releases new data to its Aromatic Amines project users
26 November 2020

Recent Blog Articles

The top 5 benefits of data sharing with Vitic [an infographic]
Lhasa Limited has been an advocate of data sharing for many years. In this piece, we explore the top 5 benefits of data sharing with Vitic.
08 April 2021
Moving with the times; Lhasa’s cloud offerings
30 March 2021
How to better anticipate and mitigate adverse drug reactions [an infographic]
17 February 2021

Archive

This is a library of Lhasa's blog articles.

5 minutes
Effiris: A secondary pharmacology model suite powered by privacy-preserving data sharing
Artificial Intelligence (AI) has become a powerful force within the pharmaceutical industry, catalysed by the challenging lengthy and costly drug development process. To maximize the impact of AI, it is critical to have access to enough good quality data to allow machine learning algorithms to extract relevant knowledge and produce valuable models.
- Innovation
21 May 2020
less than 5 minutes
How to better anticipate and mitigate adverse drug reactions [an infographic]
Are you interested in using your data to anticipate and mitigate adverse drug reactions? The Effiris consortium - currently composed of Takeda, GSK and UCB - is working to achieve just that.
- Innovation
17 February 2021

Sitemap

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.